loading
전일 마감가:
$1.83
열려 있는:
$1.8
하루 거래량:
455.42K
Relative Volume:
0.42
시가총액:
$145.95M
수익:
$153.73M
순이익/손실:
$-106.79M
주가수익비율:
-0.9944
EPS:
-1.78
순현금흐름:
$-115.93M
1주 성능:
-1.12%
1개월 성능:
-11.06%
6개월 성능:
-61.18%
1년 성능:
-61.85%
1일 변동 폭
Value
$1.7601
$1.88
1주일 범위
Value
$1.76
$1.945
52주 변동 폭
Value
$1.51
$6.13

Sutro Biopharma Inc Stock (STRO) Company Profile

Name
명칭
Sutro Biopharma Inc
Name
전화
650-392-8412
Name
주소
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
직원
306
Name
트위터
@SutroBio
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
STRO's Discussions on Twitter

STRO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
STRO
Sutro Biopharma Inc
1.77 145.95M 153.73M -106.79M -115.93M -1.78
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.24 124.35B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
700.33 76.56B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
644.48 39.16B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
250.59 32.44B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
BNTX
Biontech Se Adr
120.01 28.77B 3.30B -501.07M 1.03B -2.1146

Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-05-08 개시 BofA Securities Buy
2023-11-09 개시 Deutsche Bank Buy
2023-10-06 개시 Oppenheimer Outperform
2023-03-21 다운그레이드 Wells Fargo Overweight → Equal Weight
2022-08-18 재개 Wells Fargo Overweight
2021-06-18 개시 H.C. Wainwright Buy
2020-12-03 개시 Stifel Buy
2020-09-02 개시 Jefferies Buy
2020-07-16 개시 Wells Fargo Overweight
2020-01-13 개시 SunTrust Buy
2019-10-07 개시 BTIG Research Buy
2019-07-18 개시 Deutsche Bank Buy
2019-04-29 개시 H.C. Wainwright Buy
2018-10-22 개시 JMP Securities Mkt Outperform
2018-10-22 개시 Piper Jaffray Overweight
2018-10-22 개시 Wedbush Outperform
모두보기

Sutro Biopharma Inc 주식(STRO)의 최신 뉴스

pulisher
Feb 21, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Baillie Gifford & Co. - MarketBeat

Feb 21, 2025
pulisher
Feb 18, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $11.13 Average PT from Analysts - MarketBeat

Feb 18, 2025
pulisher
Feb 15, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 15, 2025
pulisher
Feb 14, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by SG Americas Securities LLC - Defense World

Feb 14, 2025
pulisher
Feb 13, 2025

Sutro Biopharma stock hits 52-week low at $1.67 amid market challenges - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

Shareholders in Sutro Biopharma (NASDAQ:STRO) have lost 86%, as stock drops 18% this past week - Simply Wall St

Feb 12, 2025
pulisher
Feb 11, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

Feb 11, 2025
pulisher
Feb 06, 2025

Sutro Biopharma Inc (STRO) can make a big difference with a little luck - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

Market Insights: Sutro Biopharma Inc (STRO)’s Notable Drop of -1.04, Closing at 1.90 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Have you been able to find a good deal on Sutro Biopharma Inc’s shares? - US Post News

Feb 04, 2025
pulisher
Jan 22, 2025

We're Not Very Worried About Sutro Biopharma's (NASDAQ:STRO) Cash Burn Rate - Yahoo Finance

Jan 22, 2025
pulisher
Jan 20, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jan 20, 2025
pulisher
Jan 17, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Sees Large Growth in Short Interest - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Barclays PLC Acquires 216,757 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Sutro Biopharma stock hits 52-week low at $1.7 amid market challenges - Investing.com Canada

Jan 14, 2025
pulisher
Jan 11, 2025

Sutro Biopharma (NASDAQ:STRO) versus Sorrento Therapeutics (OTCMKTS:SRNEQ) Head-To-Head Comparison - Defense World

Jan 11, 2025
pulisher
Jan 09, 2025

Jane Street Group LLC Acquires 25,416 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025
pulisher
Jan 07, 2025

Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

Sutro Biopharma Achieves Breakthrough: Cell-Free Cancer Drug Production Scales to 4,500L - StockTitan

Jan 07, 2025
pulisher
Jan 07, 2025

Great week for Sutro Biopharma, Inc. (NASDAQ:STRO) institutional investors after losing 42% over the previous year - Simply Wall St

Jan 07, 2025
pulisher
Jan 04, 2025

Geode Capital Management LLC Has $6.43 Million Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Jan 04, 2025
pulisher
Jan 02, 2025

Sutro Biopharma: I Don't Buy That Their Pipeline Is Worthless (NASDAQ:STRO) - Seeking Alpha

Jan 02, 2025
pulisher
Jan 02, 2025

ADCs continue to sizzle, inspiring major deals - BioWorld Online

Jan 02, 2025
pulisher
Dec 31, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Barclays PLC - Defense World

Dec 31, 2024
pulisher
Dec 29, 2024

Short Interest in Sutro Biopharma, Inc. (NASDAQ:STRO) Expands By 19.4% - MarketBeat

Dec 29, 2024
pulisher
Dec 29, 2024

State Street Corp Buys 81,855 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Dec 29, 2024
pulisher
Dec 23, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Dec 23, 2024
pulisher
Dec 23, 2024

Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $11.13 Consensus PT from Analysts - MarketBeat

Dec 23, 2024
pulisher
Dec 19, 2024

Sutro Biopharma, Inc.'s (NASDAQ:STRO) latest 24% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance

Dec 19, 2024
pulisher
Dec 19, 2024

Charles Schwab Investment Management Inc. Acquires 35,167 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Sutro Biopharma stock hits 52-week low at $2.02 By Investing.com - Investing.com Canada

Dec 19, 2024
pulisher
Dec 18, 2024

Fmr LLC Acquires 37,701 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

Sutro Biopharma stock hits 52-week low at $2.02 - Investing.com

Dec 18, 2024
pulisher
Dec 16, 2024

BNP Paribas Financial Markets Boosts Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World

Dec 16, 2024

Sutro Biopharma Inc (STRO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Sutro Biopharma Inc 주식 (STRO) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Gerber Hans-Peter
CHIEF SCIENTIFIC OFFICER
Sep 18 '24
Option Exercise
0.00
37,500
0
37,500
Chung Jane
PRESIDENT AND COO
Aug 09 '24
Option Exercise
0.00
18,750
0
60,951
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
May 01 '24
Option Exercise
0.00
2,500
0
32,622
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Apr 11 '24
Option Exercise
0.00
21,250
0
37,704
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 05 '24
Option Exercise
0.00
8,750
0
76,060
NEWELL WILLIAM J
CEO
Mar 05 '24
Option Exercise
0.00
18,750
0
226,893
ALBINI EDWARD C
CFO AND SECRETARY
Mar 05 '24
Option Exercise
0.00
8,750
0
109,843
NEWELL WILLIAM J
CEO
Mar 04 '24
Option Exercise
0.00
31,125
0
219,248
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Mar 04 '24
Option Exercise
0.00
9,125
0
71,049
Chung Jane
PRESIDENT AND COO
Mar 04 '24
Option Exercise
0.00
7,875
0
44,410
$33.42
price up icon 0.27%
$81.06
price down icon 3.05%
$361.10
price down icon 1.70%
$22.12
price down icon 4.08%
biotechnology ONC
$255.37
price up icon 4.57%
$120.01
price up icon 1.81%
자본화:     |  볼륨(24시간):